title: [Psoriasis vulgaris in children and adolescents. Pathogenesis, clinical picture and therapy].
abstract: BACKGROUND
  The prevalence of psoriasis vulgaris in childhood ranges from 0.12 % in infants to 1.2 % in adolescents. Psoriasis is a polygenic disease triggered by external factors and is influenced by comorbidities such as obesity, metabolic syndrome, chronic inflammatory bowel diseases and rheumatic diseases.
  
  
  METHODS
  Its clinical presentation is variable. Typical complications include erythroderma, disseminated pustulosis and arthropathy.
  
  
  METHODS
  Amongst a wide range of topical or systemic therapeutical options, individualized treatment is based on severity, site and extent of cutaneous involvement, age, potential side-effects and comorbidities.
authors: Abt. Pädiatrische Dermatologie und Allergologie, Kath. Kinderkrankenhaus Wilhelmstift Hamburg, Liliencronstr. 130, 22149, Hamburg, Deutschland, hoeger@kkh-wilhelmstift.de.
authors: P H
authors: PH
authors: Höger
authors: H
authors: H
authors: Hamm
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011565:Psoriasis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D055815:Young Adult
chemical_list: D003879:Dermatologic Agents